Product Images Tadalafil

This is a label of NuCare Pharmaceuticals Inc. for their product "Tadalafil 5mg." The label states that the medication should be kept away from children and stored at a controlled temperature of 68-77°F. The label also contains information about the product's lot number, NDC, MFR NDC, and expiration date. There is a caution about side effects and a number to call for medical advice.*

This text describes a graph or chart showing the change from baseline in IPSS (International Prostate Symptom Score) total score over the course of a treatment lasting 12 weeks. Two treatments are being compared: Tadalafil Tablets at a dose of 5 mg and placebo. The graph appears to show that treatment with Tadalafil resulted in a significant improvement in IPSS score compared to placebo, as indicated by a p-value of less than 0.01.*

The text describes a study or experiment involving the IPSS Total Score which measures symptoms of prostate enlargement. The study compares the effects of Tadalafil Tablets 5 mg versus Placebo over a certain duration of treatment in weeks, and the results indicate a significant difference between the two with a p-value of less than 0.01. However, the rest of the text appears to be garbled and not readable.*

This is a clinical data table showing the IPSS Total Score for individuals who were administered Tadalafil Tablets 5 mg versus Placebo over a course of treatment weeks. The score results are denoted by letters and symbols and are labeled "H," "F," "-", "a," "£," "2!," "°," "3," "S," "0," and "2." The asterisk indicates statistical significance with a p-value of less than 0.01.*

This is a table with data related to the effects of different treatments on blood pressure (systolic BP) at different times (not specified due to errors). The treatments include a combination of 20 mg tadalafil and 8 mg qd doxazosin at 08:00 or 20:00, and a placebo combined with 8 mg qd doxazosin at 08:00. No further information on the context or purpose of the study is available.*

This appears to be a graph showing plasma concentration of tadalafil, a medication used to treat erectile dysfunction, over time. The graph shows the concentration in micrograms per liter (ug/L) at various time points up to 120 hours (or 5 days) after administration. The different lines represent different dosages and schedules of tadalafil administration. The "a" line represents a single 5-mg dose, the "-" line represents a single 20-mg dose, and the "e" line represents once-daily 5-mg doses for 5 consecutive days.*